Post-acute neurological sequelae of COVID-19 affect millions of people worldwide, yet little
data is available to guide treatment strategies for the most common symptoms. We …

COVID-19 has been a transformative novel disease in modern health care. Unlike many
other viral illnesses, COVID-19 not only causes multiorgan damage during the acute stage …

As of May 2022, there have been more than 527 million infections with severe acute
respiratory disease coronavirus type 2 (SARS-CoV-2) and over 6.2 million deaths from …

There is accumulating evidence of the neurological and neuropsychiatric features of
infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to …

Background Covid-19 became a global pandemic in 2019. Studies have shown that
coronavirus can cause neurological symptoms, but clinical studies on its neurological …

With a growing number of patients entering the recovery phase following infection with
SARS-CoV-2, understanding the long-term neurological consequences of the disease is …

Importance Neurological and neuropsychiatric symptoms that persist or develop three
months after the onset of COVID-19 pose a significant threat to the global healthcare system …

Aims: In response to the rapid spread of COVID-19, this paper provides health professionals
with better accessibility to available evidence, summarising findings from a systematic …

Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
December 2019, causing human coronavirus disease 2019 (COVID-19), which has now …

The coronavirus can infect the upper respiratory tract, sinuses, and nose, and its severity
manifests in its respiratory symptoms and neurological and psychological consequences …